Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Src/Bcr Abl
  • PDGFR
  • VEGFR
  • FGFR
  >   TG100572
TG100572 Chemical Structure

TG100572

Data Sheet For research use only. Not for human use.
Cat. No. :BCP18234CAS No. :867334-05-2Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 867334-05-2 Cat. No. BCP18234
Name TG100572
Synonyms TG-100572;TG 100572;
SMILES
Chemical Name
Formula C26H26ClN5O2 M. Wt 475.97
Purity 98% Storage Store at 4-8°C
Description in vitro: TG100572 inhibited vascular endothelial cell proliferation in vitro (ED50= 610 ± 71 nM, mean ± SEM, N= 3) and blocked VEGF-induced phosphorylation of extracellular signal-regulated kinase (ERK), a signaling event in VEGF-induced mitogenesis. Additionally, TG100572 induced apoptosis in rapidly proliferating, but not quiescent, endothelial cell cultures . TG100572 inhibits downstream molecules involved in the vascular endothelial growth factor (VEGF) signaling pathway resulted in markedly diminished levels of HSV-induced angiogenesis and significantly reduced the severity of SK lesions. in vivo: Mice that received daily intraperitoneal injections of TG100572 (5 mg/kg) developed smaller CNV lesions than those seen in vehicle-injected mice; measuring CNV area using image analysis techniques demonstrated a 40% reduction compared to the vehicle control group.TG100572-treated group also lost an average 11% of their body weight over the 14 day course of this study compared to the veh
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:TG100572 supplier,TG100572 purchase,TG100572 manufacturer,TG100572 distributor,TG100572 cost,TG100572 buy,TG100572 for sale

0086-13720134139